Laura H. Aberle

A Registry-Based Randomized Trial Comparing Radial and Femoral Approaches in Women Undergoing Percutaneous Coronary Intervention

Sunil V. Rao, Connie N. Hess, Britt Barham et al. · JACC: Cardiovascular Interventions · 2014 · 247 citations

Medicine, Cardiology, Surgery +12

The Database for Aggregate Analysis of ClinicalTrials.gov (AACT) and Subsequent Regrouping by Clinical Specialty

Asba Tasneem, Laura H. Aberle, Hari Ananth et al. · PLoS ONE · 2012 · 169 citations · Full text

Medicine, Biomedical Informatics, Clinical Sciences +16

Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial

L. Kristin Newby, Michael Marber, Chiara Melloni et al. · The Lancet · 2014 · 155 citations

Medicine, Cardiology, Pharmacology +14

A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial

Thomas J. Povsic, John P. Vavalle, Laura H. Aberle et al. · European Heart Journal · 2012 · 108 citations · Full text

Medicine, Cardiology, Pharmacology +16

First Clinical Application of an Actively Reversible Direct Factor IXa Inhibitor as an Anticoagulation Strategy in Patients Undergoing Percutaneous Coronary Intervention

Mauricio G. Cohen, Drew A. Purdy, Joseph S. Rossi et al. · Circulation · 2010 · 98 citations

Medicine, Cardiology, Pharmacology +17